Table 3.
Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022–2030a | Unit | Rate ratio, 2022/2015 | Absolute numbers, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Age 0–4 years | ||||||||||||
All cases | 873 | 866 | 812 | 691 | 607 | 551 | 512 | 486 | 341 | Per 1000 | 0.39 | 27,851,814 |
Uncomplicated cases | 800 | 794 | 745 | 635 | 558 | 507 | 472 | 448 | 316 | Per 1000 | 0.40 | 25,532,547 |
Severe cases | 73 | 72 | 67 | 56 | 49 | 44 | 40 | 38 | 24 | Per 1000 | 0.33 | 2,319,267 |
Deaths | 335 | 318 | 299 | 255 | 224 | 203 | 187 | 176 | 141 | Per 100,000 | 0.44 | 102,368 |
Age 5–15 years | ||||||||||||
All cases | 380 | 374 | 351 | 301 | 266 | 245 | 231 | 223 | 185 | Per 1000 | 0.50 | 18,439,829 |
Uncomplicated cases | 370 | 364 | 342 | 293 | 260 | 239 | 226 | 218 | 182 | Per 1000 | 0.50 | 17,959,175 |
Severe cases | 10 | 10 | 9.1 | 7.6 | 6.5 | 5.8 | 5.4 | 5.1 | 3.4 | Per 1000 | 0.35 | 480,654 |
Deaths | 15 | 15 | 14 | 12 | 11 | 10 | 10 | 10 | 10 | Per 100,000 | 0.66 | 7484 |
Age 15+ years | ||||||||||||
All cases | 146 | 146 | 137 | 118 | 105 | 98 | 93 | 91 | 75 | Per 1000 | 0.51 | 14,890,633 |
Uncomplicated cases | 145 | 145 | 136 | 117 | 105 | 97 | 93 | 91 | 74 | Per 1000 | 0.51 | 14,800,267 |
Severe cases | 0.9 | 0.9 | 0.8 | 0.7 | 0.6 | 0.5 | 0.4 | 0.4 | 0.3 | Per 1000 | 0.33 | 90,365 |
Deaths | 5.9 | 5.9 | 5.5 | 4.6 | 4.1 | 3.7 | 3.5 | 3.4 | 3.9 | Per 100,000 | 0.66 | 6043 |
All ages | ||||||||||||
All cases | 336 | 333 | 312 | 266 | 234 | 214 | 200 | 192 | 148 | Per 1000 | 0.44 | 61,182,276 |
Uncomplicated cases | 321 | 318 | 297 | 254 | 224 | 205 | 192 | 184 | 143 | Per 1000 | 0.45 | 58,291,990 |
Severe cases | 16 | 16 | 15 | 12 | 10 | 9.3 | 8.5 | 7.9 | 5.0 | Per 1000 | 0.32 | 2890,286 |
Deaths | 66 | 63 | 59 | 50 | 43 | 39 | 36 | 34 | 28 | Per 100,000 | 0.44 | 115,894 |
PfPR 2–9 years | 27 | 27 | 25 | 22 | 19 | 18 | 17 | 16 | 11 | % | 0.41 |
aSame projected annual rates every year over 2022 throughout 2030